Abbott Labs Sells Developed Markets Generics Unit

July 14 (Bloomberg) -- Marshall Sonenshine, chairman and managing partner at Sonenshine Partners, and Jonathan Golub, chief U.S. market strategist at RBC Capital Markets, examine Abbott Laboratories selling its developed markets generic drug unit to Mylan in a deal worth $5.3 Billion and what it means to the current M&A market. They speak on “Bloomberg Surveillance.”
Future of Sales and Branding Is Social Media: Joseph
20:00 - In today's "Brandstanding" segment, Instagram Artist and Photographer Murad Osmann and Bochic Co-Founder and Creative Director David Joseph discuss their collaboration on their "Follow Me" Instagram campaign, how they interact with their customers and how they consider the "soft sell" the best approach. They speak with Bloomberg's Rishaad Salamat on "Trending Business." (Source: Bloomberg)
  • We Are in the Age of the Customer: Colony
  • Stolen Nazi Art Case Depicted in `Woman in Gold'
  • Tim Gunn: `Making It Work' in Fashion and Business